Bipolar disorder (BD), recurrent depression and treatment resistant depression (TRD) are associated with dysregulation in the cellular signalling pathways that influence brain function and thereby behavioural performance but it is not fully elucidated whether peripheral BDNF potentially can serve as a biomarker in these disorders [2;3]. This evidence concerns the gene BDNF and treatment resistant depression.